EHC — Encompass Health Corporation

Encompass Health (EHC) Q4 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• Q4 Revenue: Increased by 9.9% to $1.5 billion.
• Adjusted EBITDA: Rose by 15.9% to $335.6 million.
• Full Year 2025 Revenue: Grew 10.5%, driven by 6% discharge growth and pricing improvements.
• Full Year 2025 EBITDA: Increased 14.9%, aided by disciplined expense management.
• Q4 Bad Debt Expense: Held steady at 2.1%.
• Adjusted Free Cash Flow: Increased 23.6% to $235.4 million for Q4, totaling $818 million for 2025.
• Net Financial Leverage: Year-end ratio of 1.9x, indicating strong balance sheet flexibility.

2. Strategic Updates and Business Highlights

• Capacity Expansion: Added 517 beds in 2025, including 390 from 8 new hospitals and 127 from existing facilities.
• New Initiatives: Plans to introduce small-format hospitals in 2027 to enhance market presence.
• ERP System Upgrade: Successfully transitioned to Oracle Fusion, enhancing operational efficiency.
• Regulatory Engagement: Active discussions with CMS regarding reimbursement criteria and RCD implementation, achieving a 93% affirmation rate in Alabama.
• Partnership with Palantir: Extended collaboration focusing on improving claims management and operational efficiencies.

3. Forward Guidance and Outlook

• 2026 Guidance:
  • Net operating revenue projected between $6.365 billion and $6.465 billion.
  • Adjusted EBITDA expected to range from $1.34 billion to $1.38 billion.
  • Adjusted earnings per share forecasted between $5.81 and $6.10.

4. Bad News, Challenges, or Points of Concern

• Medicare Advantage (MA) Conversion Rates: Notable decline in conversion rates from a major national payer, impacting admissions despite increased referrals.
• Regulatory Changes: Ongoing concerns regarding the RCD and TEAM models, although management believes they can mitigate impacts based on historical performance.
• Volume Headwinds: Anticipated impact from unit consolidations and closures, particularly in Q1 2026, estimated to create a 70-basis-point headwind for discharge growth.
• Labor Costs: While premium labor costs have decreased, ongoing labor market pressures remain a concern.

5. Notable Q&A Insights

• Volume Dynamics: Management acknowledged challenges in the latter half of 2025 due to difficult comparisons from the previous year and new hospital openings impacting same-store metrics.
• Medicare Advantage Strategy: Plans to implement an admit and appeal strategy for MA denials, emphasizing compliance with Medicare coverage requirements.
• Team Model Impact: Management expressed confidence in mitigating potential volume loss from the TEAM model, citing a significant population of IRF-appropriate patients still needing care.
• Small Format Hospitals: The introduction of small-format hospitals is seen as a strategic move to address market demand without the need for extensive new certifications or renegotiations with payers.

Overall, Encompass Health reported strong financial performance in Q4 2025, with strategic initiatives aimed at expanding capacity and improving operational efficiency. However, challenges related to Medicare Advantage conversions and regulatory changes present potential headwinds moving forward.